Back to News
Market Impact: 0.35
PTC Therapeutics Board of Directors Authorizes $500 Million Share Repurchase Program
Source: PR Newswire
Capital Returns (Dividends / Buybacks)Company Fundamentals
PTC Therapeutics’ board authorized a share repurchase program allowing the company to buy back up to $500 million of its outstanding common shares. Repurchases are subject to market conditions; the article provides no timing or additional program details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
PTCT0.50
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AMD rides data center riches to ‘largest and most profitable’ quarter in history
- AMD’s OpenAI, Meta chip deals trigger $1 billion quarterly charge